Jonathan Kil
Algemeen Directeur bij Sound Pharmaceuticals, Inc.
Profiel
Jonathan Kil is the founder.
He founded Otogene in 1998 and Sound Pharmaceuticals, Inc. in 2002, where he currently holds the title of Director, Chief Executive & Medical Officer.
Dr. Kil has a doctorate degree from the University of Virginia and an undergraduate degree from the University of California, Irvine.
Actieve functies van Jonathan Kil
Bedrijven | Functie | Begin |
---|---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Algemeen Directeur | 01-02-2002 |
Eerdere bekende functies van Jonathan Kil
Bedrijven | Functie | Einde |
---|---|---|
Otogene | Oprichter | - |
Opleiding van Jonathan Kil
University of Virginia | Doctorate Degree |
University of California, Irvine | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
Otogene |